Bridging the Gap to Success in Humans
We are dedicated to transforming this discovery into technologies that bridge the gap between preclinical studies and first-in-human trials.
With this technology, we are accelerating the development of safe, effective, and personalized treatments by replacing uncertainty with precision, helping researchers and innovators bring life-changing therapies to people faster and with greater confidence.
Team
Chief Executive Officer
Jordana is an accomplished entrepreneur and strategic leader with over 15 years of experience in product development, business growth, and commercial partnerships. She has a strong track record in securing funding, operations and strategic direction and is jointly responsible for OmnigeniQ’s vision.
Chief Science Officer
Tiffanwy Klippel-Cooper is an innovative thinker and a voracious inventor holding five degrees in genetics, biological sciences, medical sciences, and pathology. She brings extensive experience in scientific innovation, independent research, and technology development for health and space applications.
Biopharma & Regulatory
Rosa Miles brings 26 years of global experience in biotechnology, pharmaceuticals, and healthcare. She is a recognised expert in clinical research, regulatory affairs, CMC strategy, and product development across multiple therapeutic areas, including advanced cell and gene therapies.
AI/ML & Bioinformatics
Dr Lauren Urban is a senior data scientist and molecular biologist with more than 10 years of experience in advanced analytics, artificial intelligence, and bioinformatics. She specialises in building AI models, predictive analytics, and cheminformatics solutions for healthcare and medical research.